A Win For Kiora Pharmaceuticals Inc.
Thu, Aug 25, 2022 at 07:01 PM
Kiora Pharmaceuticals Inc. (KPRX:NASDAQ) jumped higher at $0.26, representing a gain of 95.3%. On Thu, Aug 25, 2022, KPRX:NASDAQ touched a New 2-Week High of $0.26. The stock got featured on our News Catalysts scanner on Fri, Aug 12, 2022 at 09:31 AM in the 'EARNINGS' category. From Thu, Aug 11, 2022, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Jun 08, 2022 at $0.66 with a volume of 8M+.
About Kiora Pharmaceuticals Inc. (KPRX:NASDAQ)
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye.
Top 10 Gainers:
- Kiora Pharmaceuticals Inc. (KPRX:NASDAQ), 95.31%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 45.96%
- Golden Sun Education Group Limited (GSUN:NASDAQ), 38%
- Renovare Environmental Inc. (RENO:NASDAQ), 36.85%
- Vaccitech plc (VACC:NASDAQ), 31.98%
- Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 29.14%
- Snowflake Inc. Class A (SNOW:NYSE), 23.07%
- MSP Recovery Inc. (MSPR:NASDAQ), 22.46%
- Wah Fu Education Group Limited (WAFU:NASDAQ), 21.91%